Class II · Moderate risk
Is Finasteride recalled?
Yes — there is an active recall. 2 ongoing FDA recalls mention Finasteride (17 total). Check the affected lots below.
Most common reason: cGMP deviation (8 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Finasteride. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Finasteride recalls on record
none so far in 2026; 17 on record, newest first
Class II · Moderate risk
Finasteride Tablets
cGMP Deviations for the manufacturing Firm (Accord Healthcare) after their inspection.
Class II · Moderate risk
Finasteride
cGMP deviations
Class II · Moderate risk
Finasteride Tablets USP
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Finasteride Tablets USP 1 mg
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Finasteride Tablets USP
CGMP Deviations: recalling drug products following an FDA inspection.
Class II · Moderate risk
Formula 82F
Lack of Processing Controls (lack of assurance of conformity to specifications).
Class II · Moderate risk
Finasteride Plus 1.25mg Capsule
Lack of Processing Controls (lack of assurance of conformity to specifications).
Class I · High risk
Finasteride Plus 1.25 mg Capsule
Cross Contamination with Other Products; Finasteride Plus 1.25mg capsules were found to contain minoxidil.
Class II · Moderate risk
Finasteride/Biotin 1 mg/50 mcg
Labeling: Incorrect or missing lot and/or expiration date. Products were compounded using expired components.
Class II · Moderate risk
Testosterone/Finasteride 80 mg/8 mg pellet
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Class II · Moderate risk
Testosterone/Finasteride/Anastrozole 120 mg/10 mg/4 mg pellet Amber vial
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Class II · Moderate risk
Testosterone/Finasteride 60 mg/5 mg pellet Amber vial
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Class II · Moderate risk
Testosterone/Estradiol 60 mg/6 mg pellet Amber vial
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Class III · Low risk
Finasteride Tablets
Failed Tablet/Capsule Specification: Tablets were found to be twice the thickness in one lot of product.
Class II · Moderate risk
Finasteride active pharmaceutical ingredient packaged in varying…
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Class II · Moderate risk
FINASTERIDE Tablet
Labeling: Label Mixup; FINASTERIDE, Tablet, 5 mg may be potentially mislabeled as DIGOXIN, Tablet, 0.125 mg, NDC 00115981101, Pedigree: AD62829_8, EXP: 5/23/2014; PHYTONADIONE, Tablet, 5 mg, NDC 25010040515, Pedigree: W003061, EXP: 5/31/2014.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.